Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Vienna Insurance Group, Valneva (27/11/2023)

03.12.2023

Vienna Insurance Group: Vienna Insurance Group lets its shareholders continuously participate in its success since its initial listing on the Vienna Stock Exchange in 1994. With regard to dividend continuity and predictability VIG aims to pay in the future a dividend per share that is at least equal to that of the previous year and increases continuously depending on the operating earnings situation. In order to reflect the resilience of the business model also in the dividend, the Management Board of VIG for the first time sets the minimum dividend at the respective previous year’s level, based on the Groups capital strength. The dividend per share for the 2023 financial year will therefore amount to at least EUR 1.30 in accordance with the dividend policy adopted today. The final dividend proposal will be communicated by the Management Board with the preliminary results for 2023. The dividend policy so far was linked to Group net profits and provided for a distribution in the range of 30 to 50%.
VIG: weekly performance: -0.19%

Valneva: Valneva, a specialty vaccine company, announced that the European Medicines Agency (EMA) has performed a technical validation of the Marketing Authorization Application (MAA) for Valneva’s single-shot chikungunya vaccine candidate VLA1553 and has determined that all essential regulatory elements required for scientific assessment were included in the application. The MAA was granted accelerated assessment last month by EMA’s Committee for Medicinal Products for Human Use (CHMP) based on the vaccine candidate’s “major interest for public health and therapeutic innovation”.
Valneva: weekly performance: -0.27%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (27/11/2023)


Partners









latest 21st Austria

21st Austria weekly - Vienna Insurance Group, Valneva (27/11/2023)


03.12.2023, 1755 Zeichen



Vienna Insurance Group: Vienna Insurance Group lets its shareholders continuously participate in its success since its initial listing on the Vienna Stock Exchange in 1994. With regard to dividend continuity and predictability VIG aims to pay in the future a dividend per share that is at least equal to that of the previous year and increases continuously depending on the operating earnings situation. In order to reflect the resilience of the business model also in the dividend, the Management Board of VIG for the first time sets the minimum dividend at the respective previous year’s level, based on the Groups capital strength. The dividend per share for the 2023 financial year will therefore amount to at least EUR 1.30 in accordance with the dividend policy adopted today. The final dividend proposal will be communicated by the Management Board with the preliminary results for 2023. The dividend policy so far was linked to Group net profits and provided for a distribution in the range of 30 to 50%.
VIG: weekly performance: -0.19%

Valneva: Valneva, a specialty vaccine company, announced that the European Medicines Agency (EMA) has performed a technical validation of the Marketing Authorization Application (MAA) for Valneva’s single-shot chikungunya vaccine candidate VLA1553 and has determined that all essential regulatory elements required for scientific assessment were included in the application. The MAA was granted accelerated assessment last month by EMA’s Committee for Medicinal Products for Human Use (CHMP) based on the vaccine candidate’s “major interest for public health and therapeutic innovation”.
Valneva: weekly performance: -0.27%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (27/11/2023)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #777: ATX schwächer, Palfinger und RWT glauben an sich und am Montag kommt The One and Only




 

Bildnachweis

Aktien auf dem Radar:Warimpex, RBI, Andritz, Immofinanz, CA Immo, Addiko Bank, Agrana, Frequentis, Pierer Mobility, AT&S, Cleen Energy, FACC, Lenzing, Linz Textil Holding, SW Umwelttechnik, EuroTeleSites AG, Oberbank AG Stamm, Zumtobel, Kapsch TrafficCom, Amag, Erste Group, EVN, Flughafen Wien, OMV, Österreichische Post, S Immo, Telekom Austria, Uniqa, VIG, Wienerberger.


Random Partner

Croma
Croma Pharma® ist ein österreichisches Familienunternehmen mit Sitz in Leobendorf. Das Unternehmen ist auf die industrielle Fertigung von Hyaluronsäure-Spritzen spezialisiert und zählt in diesem Bereich europaweit zu den führenden Experten. Das Unternehmen setzt mit eigenen Marken auf die Wachstumssparte der minimalinvasiven ästhetischen Medizin.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten